Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Jia Qing Xiang"'
Autor:
Hang Li, Ze‐Lin Ma, Bin Li, Yun‐jian Pan, Jia‐Qing Xiang, Ya‐Wei Zhang, Yi‐Hua Sun, Ting Hou, Analyn Lizaso, Yan Chen, Xi Li, Hong Hu
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8377-8386 (2021)
Abstract Growing efforts are being invested in investigating various molecular approaches to detect minimal residual disease (MRD) and predict disease recurrence. In our study, we investigated the utility of parallel longitudinal analysis of mutation
Externí odkaz:
https://doaj.org/article/f9cf44dbf7b144dd826ad9e7c78bdd6b
Publikováno v:
In Inorganica Chimica Acta 2010 363(11):2481-2487
Autor:
Mei-Ling Zhu, Ting-Yan Shi, Hai-Chuan Hu, Jing He, Mengyun Wang, Li Jin, Ya-Jun Yang, Jiu-Cun Wang, Meng-Hong Sun, Huan Chen, Kuai-Le Zhao, Zhen Zhang, Hai-Quan Chen, Jia-Qing Xiang, Qing-Yi Wei
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41500 (2012)
BACKGROUND: Excision repair cross complementing group 5 (ERCC5 or XPG) plays an important role in regulating DNA excision repair; its functional single nucleotide polymorphisms (SNPs) may alter DNA repair capacity and thus contribute to cancer risk.
Externí odkaz:
https://doaj.org/article/4d324119e985493b9b41391d255016d8
Autor:
Ling Li, Li Yi Xie, Haiquan Chen, C. Shun Wong, Mei Kang, Guo-Liang Jiang, Yin Xu, Hong-Bing Wang, Xing Wen Fan, Wen Tao Fang, Yu Yang, Kai-Liang Wu, Jia Qing Xiang, Yee C. Ung, Kuai le Zhao
Publikováno v:
International journal of radiation oncology, biology, physics. 107(1)
Purpose This prospective phase 2 study evaluated the efficacy and safety of intensity modulated radiation therapy plus etoposide/cisplatin (EP) for patients with unresectable thymic epithelial tumors (TETs). Methods and Materials Patients with limite
Autor:
Meiling Zhu, Xiaofeng Wang, Jia Qing Xiang, Jing He, Mengyun Wang, Yajun Yang, Li Jin, Qingyi Wei, Jinhong Zhu, Jiucun Wang
Publikováno v:
Journal of Cellular and Molecular Medicine. 20:666-677
Ethnic Han Chinese are at high risk of developing oesophageal squamous cell carcinoma (ESCC). Aberrant activation of the AKT signalling pathway is involved in many cancers, including ESCC. Some single nucleotide polymorphisms (SNPs) in genes involved
Autor:
Haiquan Chen, Xiaolong Fu, Zheng Fei Zhu, Wen Feng, Jia Qing Xiang, Lei Shen, Jian Hua Chang, Ya Wei Zhang, Yuan Li, Xu wei Cai
Publikováno v:
Oncotarget
// Wen Feng 1, 2, * , Yuan Li 3, * , Lei Shen 3 , Xu-Wei Cai 1 , Zheng-Fei Zhu 2 , Jian-Hua Chang 4 , Jia-Qing Xiang 5 , Ya-Wei Zhang 5 , Hai-Quan Chen 5 , Xiao-Long Fu 1, 2 1 Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao T
Publikováno v:
Oncotarget
// Qi Liu 1, 2, * , Xu-Wei Cai 1, 2, 3, * , Xiao-Long Fu 1, 2, 3 , Jun-Chao Chen 1, 2 , Jia-Qing Xiang 2, 4 1 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China 2 Department of Oncology, Shanghai Medical Colleg
Autor:
Kai-Liang Wu, Xiaolong Fu, Jia Qing Xiang, Haiquan Chen, Min Fan, Wen Feng, Ya Wei Zhang, Xu Wei Cai, Huan Jun Yang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 88:1100-1107
Purpose To analyze patterns of local-regional failure (LRF) for completely resected stage IIIA(N2) non-small cell lung cancer (NSCLC) patients treated in our hospital and to propose a clinical target volume (CTV) for postoperative radiation therapy (
Autor:
Yajun Yang, Hongping Yu, Meng Hong Sun, Jiucun Wang, Mengyun Wang, Jia Qing Xiang, Qingyi Wei, Jing He, Tingyan Shi, Mei Ling Zhu, Li Jin, Qiao Xin Li
Publikováno v:
Journal of Thoracic Oncology. 8(6):788-795
Introduction Mammalian target of rapamycin complex 1 (mTORC1) is an evolutionary conserved multiprotein complex that functions as a key regulator of gene transcription, protein translation, and autophagy. No studies have assessed associations between
Autor:
Jia Qing Xiang, Xiaolong Fu, Min Fan, Song Tao Lai, Xu Wei Cai, Guo-Liang Jiang, Xiao Yan Zhou, Haiquan Chen, K. Zhao, Xiang Hua Wu, Yuan Li, Xi chun Hu, Ning Yi Ma, Ya Wei Zhang
Publikováno v:
International Journal of Clinical Oncology. 19:297-302
We investigated nimotuzumab (h-R3), a humanized monoclonal antibody against epidermal growth factor receptor, when combined with irradiation or chemoradiation for squamous cell carcinoma (SCC) of the esophagus. The aim of this study was to evaluate i